4qfg
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | ''' | + | ==Structure of AMPK in complex with STAUROSPORINE inhibitor and in the absence of a synthetic activator== |
| - | + | <StructureSection load='4qfg' size='340' side='right' caption='[[4qfg]], [[Resolution|resolution]] 3.46Å' scene=''> | |
| - | + | == Structural highlights == | |
| - | + | <table><tr><td colspan='2'>[[4qfg]] is a 3 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4QFG OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4QFG FirstGlance]. <br> | |
| - | + | </td></tr><tr><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=AMP:ADENOSINE+MONOPHOSPHATE'>AMP</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene>, <scene name='pdbligand=STU:STAUROSPORINE'>STU</scene><br> | |
| - | + | <tr><td class="sblockLbl"><b>[[Non-Standard_Residue|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=TPO:PHOSPHOTHREONINE'>TPO</scene></td></tr> | |
| - | + | <tr><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4qfs|4qfs]], [[4qft|4qft]]</td></tr> | |
| + | <tr><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4qfg FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4qfg OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4qfg RCSB], [http://www.ebi.ac.uk/pdbsum/4qfg PDBsum]</span></td></tr> | ||
| + | <table> | ||
| + | __TOC__ | ||
| + | </StructureSection> | ||
| + | [[Category: Calabrese, M F.]] | ||
| + | [[Category: Kurumbail, R G.]] | ||
| + | [[Category: Ampk]] | ||
| + | [[Category: Cbm]] | ||
| + | [[Category: Kinase]] | ||
| + | [[Category: Signaling protein-inhibitor complex]] | ||
Revision as of 02:48, 7 August 2014
Structure of AMPK in complex with STAUROSPORINE inhibitor and in the absence of a synthetic activator
| |||||||||||
